Clinical Trials · NCT04093752
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 917
- Start date
- Dec 2019
- Locations
- 67 sites, 4 countries
- Primary endpoint
- Mean Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)